Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,328.00
Bid: 2,323.00
Ask: 2,325.00
Change: 44.00 (1.93%)
Spread: 2.00 (0.086%)
Open: 2,291.00
High: 2,340.00
Low: 2,284.00
Prev. Close: 2,284.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Jan 2024 07:00

RNS Number : 3498B
Halma PLC
30 January 2024
 

Halma plc ("Halma" or "Company")Directorate Change

 

Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Giles Kerr as an independent non-executive Director, with effect from 1 February 2024. Giles will also be a member of Halma's Audit, Remuneration and Nomination Committees.

 

Giles brings a wealth of experience gained across a variety of roles in life sciences, technology and industrial businesses. Giles has a particularly strong background in driving strategic business growth as well as extensive M&A experience. He is currently Chair of PayPoint plc and was Senior Independent Director & Audit Committee Chair at Abcam plc, until it was acquired by Danaher in December 2023.

 

His executive career included senior financial roles at Arthur Andersen (leading to his appointment as National Partner), Amersham plc (latterly as Group Finance Director) and as Finance Director at Oxford University Innovation. Since 2007, Giles has held a number of non-executive director roles including Elan Corporation, Victrex plc, BTG plc, Oxford Sciences Innovation plc, Arix Bioscience plc and Senior plc.

 

Roy Twite, non-executive Director, who has served for nine years on the Board, will step down as a Director on 7 June 2024.

 

Dame Louise Makin, Chair, commented:"I am delighted that Giles is joining the Halma Board. His extensive executive and non-executive experience, particularly in the life sciences and technology sectors, will bring valuable insights and perspectives to the Board.

 

I would like to thank Roy for his valuable contribution to Halma, and particularly the support that he has given to me and the Board to ensure an orderly transition and onboarding of recent executive and non-executive Directors"

 

There are no further details to be disclosed for Giles Kerr under Listing Rule 9.6.13R.

 

 

For further information, please contact:

Halma plcMarc Ronchetti, Group Chief ExecutiveSteve Gunning, Chief Financial Officer

Charles King, Head of Investor Relations

Clayton Hirst, Director of Corporate Affairs

+44 (0)1494 721 111

+44 (0)7776 685948

+44 (0)7834 796 013

MHPOliver Hughes/Rachel Farrington/Ollie Hoare

+44 (0)20 3128 8100

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGFMVGFGDZG
Date   Source Headline
5th May 201112:01 pmRNSHolding(s) in Company
4th May 20113:54 pmRNSDirector/PDMR Shareholding
3rd May 201110:46 amRNSTotal Voting Rights
4th Apr 201110:29 amRNSTotal Voting Rights
28th Mar 20114:26 pmRNSTreasury Stock
9th Mar 20117:00 amRNSAcquisition
2nd Mar 20112:33 pmRNSDirector/PDMR Shareholding
2nd Mar 201110:07 amRNSTotal Voting Rights
2nd Mar 20118:47 amRNSAcquisition
17th Feb 20117:00 amRNSInterim Management Statement
15th Feb 20112:42 pmRNSHolding(s) in Company
4th Feb 20118:45 amRNSTotal Voting Rights
25th Jan 20112:23 pmRNSBlocklisting Interim Review
19th Jan 20115:56 pmRNSTreasury Stock
4th Jan 20115:17 pmRNSTotal Voting Rights
17th Dec 20107:00 amRNSAcquisition
8th Dec 201011:44 amRNSDirector/PDMR Shareholding
2nd Dec 20103:53 pmRNSTreasury Stock
1st Dec 201010:25 amRNSTotal Voting Rights
30th Nov 201011:07 amRNSDoc re. Half Year Report 2010/11
30th Nov 20107:00 amRNSHalf Yearly Report
24th Nov 201011:22 amRNSNotice of Results
5th Nov 20104:02 pmRNSTreasury Stock
3rd Nov 20107:00 amRNSAcquisition
1st Nov 20103:51 pmRNSTotal Voting Rights
6th Oct 20104:36 pmRNSHolding(s) in Company
5th Oct 20104:19 pmRNSDirector/PDMR Shareholding
5th Oct 20102:12 pmRNSHolding(s) in Company
4th Oct 201010:11 amRNSTotal Voting Rights
29th Sep 20102:46 pmRNSTreasury Stock
7th Sep 20105:53 pmRNSDirector/PDMR Shareholding
2nd Sep 20105:12 pmRNSTotal Voting Rights
11th Aug 20104:26 pmRNSAnnual Information Update
11th Aug 20103:50 pmRNSBlocklisting Interim Review
9th Aug 20109:24 amRNSDirector/PDMR Shareholding
6th Aug 20104:35 pmRNSPrice Monitoring Extension
3rd Aug 20103:24 pmRNSDirector/PDMR Shareholding
2nd Aug 201012:55 pmRNSTotal Voting Rights
30th Jul 20104:37 pmRNSHolding(s) in Company
30th Jul 20102:14 pmRNSDirectorate Change
30th Jul 201012:52 pmRNSResult of AGM
29th Jul 20107:00 amRNSAGM Statement
7th Jul 201010:03 amRNSDirector/PDMR Shareholding
7th Jul 20109:46 amRNSTreasury Stock
6th Jul 20109:27 amRNSDirectorate Change
5th Jul 20104:45 pmRNSHolding(s) in Company
1st Jul 20103:13 pmRNSTotal Voting Rights
1st Jul 20103:13 pmRNSTotal Voting Rights
28th Jun 201011:39 amRNSAnnual Financial Report
22nd Jun 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.